Login
Latest life sciences
Big Law • 29 April 2022
Ginkgo Bioworks, Microba Life Sciences enter development agreement
NYSE-listed Ginkgo Bioworks (NYSE: DNA) has entered into a technical development agreement with ASX-listed Microba Life...
Read More
Big Law • 20 April 2022
Microba Life Sciences lists on ASX
Gut health business Microba Life Sciences (ASX: MAP) has successfully listed on the Australian Securities Exchange, in an...
Read More
Big Law • 21 January 2022
M&A high on agenda for life science companies
More life sciences companies than ever are focusing on growing via acquisition, new research from Baker McKenzie has found.
Read More
